Salas Gaston A, Lai Shuheng A, Verdugo-Paiva Francisca, Requena Roberto A
Department of Research in Health Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Oral and Maxillofacial Surgery Program, Universidad de los Andes, Santiago, Chile.
Craniomaxillofac Trauma Reconstr. 2022 Jun;15(2):164-168. doi: 10.1177/19433875211016203. Epub 2021 May 6.
The objective of this systematic review is to assess the effectiveness and safety of platelet-rich fibrin (PRF) in third molar surgery.
A comprehensive search strategy is meant to be used in an attempt to identify all relevant randomized controlled trials (RCTs), ongoing investigation reported in specialty congresses and trials regardless of language or publication status (published, unpublished, in press and in progress). Searches will be conducted in the Cochrane Central Register of Controlled Trials (CENTRAL), PUBMED, Embase, Lilacs, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH), grey literature and in specialized congresses and conferences.
We will include randomized trials evaluating the effect of PRF on wound healing after third molar surgery. Two reviewers will independently screen each study for eligibility, data extraction and risk of bias assessment using Cochrane "risk of bias" tool. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome.
As researchers will not access information that could lead to the identification of an individual participant, obtaining ethical approval was waived.
本系统评价的目的是评估富血小板纤维蛋白(PRF)在第三磨牙手术中的有效性和安全性。
旨在采用全面的检索策略,以识别所有相关的随机对照试验(RCT)、专业大会上报告的正在进行的研究以及试验,无论其语言或发表状态(已发表、未发表、即将发表和正在进行)如何。检索将在Cochrane对照试验中心注册库(CENTRAL)、PUBMED、Embase、Lilacs、国际临床试验注册平台(ICTRP)、ClinicalTrials.gov、美国国立卫生研究院(NIH)、灰色文献以及专业大会和会议中进行。
我们将纳入评估PRF对第三磨牙手术后伤口愈合影响的随机试验。两名评价者将使用Cochrane“偏倚风险”工具独立筛选每项研究的纳入资格、提取数据并评估偏倚风险。我们将使用荟萃分析汇总结果,并应用GRADE系统评估每个结局证据的确定性。
由于研究人员不会获取可能导致识别个体参与者的信息,因此无需获得伦理批准。